An adverse interaction between warfarin and capecitabine: A case report and review of the literature

Clinical colorectal cancer

Volumn 1, Issue 3, 2001, Pages 182-184

  Copur, M Sitki ^a   Ledakis, Peter ^a   Bolton, Mark ^a   Morse, Anne K ^a   Werner, Thomas ^a   Norvell, Max ^a   Muhvic, Joan ^a   Chu, Edward ^b  

^a Saint Francis Medical Center Grand Island   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Capecitabine; Drug interaction; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; WARFARIN;

AGED; BLEEDING; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; FEMALE; HUMAN; REVIEW;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DRUG INTERACTIONS; FEMALE; HEMORRHAGE; HUMANS; WARFARIN;

EID: 0035522654     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2001.n.019     Document Type: Article

References (16)

1. B Booth R Weiss Venous thrombosis during adjuvant chemotherapy N Engl J Med 305 1981 170
2. C Tashima Cyclophosphamide effect on coumarin anticoagulation South J Med 72 1979 633
3. R Chlebowski C Gota K Chan Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancer Cancer Res 42 1982 4827
4. K Ward JD Bitran Warfarin, etoposide, and vindesine interactions Cancer Treat Rep 68 1984 817 818
5. EJ Seifter BJ Brooks Jr. WJ Urba Possible interactions between warfarin and antineoplastic drugs Cancer Treat Rep 69 1985 244 245
6. JM Kolesar CL Johnson BL Freeberg Warfarin-5-FU interaction- a consecutive case series Pharmacotherapy 19 1999 1445 1449
7. JL Blum SE Jones AU Buzdar Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer J Clin Oncol 17 1999 485 493
8. F Benedetti Important prescribing information: potential Xeloda interaction with coumarin derivatives 1999 US Food and Drug Administration Available at: www.fda.gov/medwatch/safety/1999/xeloda.htm
9. T Wajima P Mukhopadhyay Possible interactions between warfarin and 5-fluorouracil Am J Hematol 40 1992 238
10. MC Brown Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil Pharmacotherapy 17 1997 631 633
11. MC Brown An adverse interaction between warfarin and 5-fluorouracil: A case report and review of the literature Chemotherapy 45 1999 392 395
12. Z Aki G Kotiloglu O Ozyilkan A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin Am J Gastroenterol 95 2000 1093 1094
13. LS Kaminsky ZY Zhang Human P450 metabolism of warfarin Pharmacol Ther 73 1997 67 74
14. R Porter W Sawyer Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. In: Evans WR, Vancouver SJ Applied Therapeutics 1992 1 46
15. A Afsar C Lee DS Riddick Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil Can J Physiol Pharmacol 74 1996 150 156
16. Xeloda Package Insert, Roche Pharmaceuticals, 2001.